Works matching AU Newman, Amy H.

Results: 27

Chiral aminophosphonate eluent for enantiomeric analysis of amino acids.

Published in:

Chirality, 1996, v. 8, n. 1, p. 122, doi. 10.1002/(SICI)1520-636X(1996)8:1<122::AID-CHIR17>3.0.CO;2-P

By:

Belov, Yuri P.;
Aksinenko, Alexei Y.;
Blessington, Bernard;
Newman, Amy H.

Publication type:

Article

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

Published in:

Frontiers in Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fnins.2021.656475

By:

Hersey, Melinda;
Bacon, Amanda K.;
Bailey, Lydia G.;
Coggiano, Mark A.;
Newman, Amy H.;
Leggio, Lorenzo;
Tanda, Gianluigi

Publication type:

Article

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25363-3

By:

Plenge, Per;
Yang, Dongxue;
Salomon, Kristine;
Laursen, Louise;
Kalenderoglou, Iris E.;
Newman, Amy H.;
Gouaux, Eric;
Coleman, Jonathan A.;
Loland, Claus J.

Publication type:

Article

Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Published in:

2019

By:

Ning-Sheng Cai;
Quiroz, César;
Bonaventura, Jordi;
Bonifazi, Alessandro;
Cole, Thomas O.;
Purks, Julia;
Billing, Amy S.;
Massey, Ebonie;
Wagner, Michael;
Wish, Eric D.;
Guitart, Xavier;
Rea, William;
Lam, Sherry;
Moreno, Estefanía;
Casadó-Anguera, Verònica;
Greenblatt, Aaron D.;
Jacobson, Arthur E.;
Rice, Kenner C.;
Casadó, Vicent;
Newman, Amy H.

Publication type:

journal article

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Published in:

Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 3107, doi. 10.1172/JCI73778

By:

Hansen, Freja H.;
Skjørringe, Tina;
Yasmeen, Saiqa;
Arends, Natascha V.;
Sahai, Michelle A.;
Erreger, Kevin;
Andreassen, Thorvald F.;
Holy, Marion;
Hamilton, Peter J.;
Neergheen, Viruna;
Karlsborg, Merete;
Newman, Amy H.;
Pope, Simon;
Heales, Simon J. R.;
Friberg, Lars;
Law, Ian;
Pinborg, Lars H.;
Sitte, Harald H.;
Loland, Claus;
Lei Shi

Publication type:

Article

Dissociable Control of Impulsivity in Rats by Dopamine D2/3 Receptors in the Core and Shell Subregions of the Nucleus Accumbens.

Published in:

Neuropsychopharmacology, 2010, v. 35, n. 2, p. 560, doi. 10.1038/npp.2009.162

By:

Besson, Morgane;
Belin, David;
McNamara, Ruth;
Theobald, David E. H.;
Castel, Aude;
Beckett, Victoria L.;
Crittenden, Ben M.;
Newman, Amy H.;
Everitt, Barry J.;
Robbins, Trevor W.;
Dalley, Jeffrey W.

Publication type:

Article

Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.

Published in:

Psychopharmacology, 2018, v. 235, n. 5, p. 1439, doi. 10.1007/s00213-018-4853-4

By:

Maggio, Sarah E.;
Saunders, Meredith A.;
Baxter, Thomas A.;
Nixon, Kimberly;
Prendergast, Mark A.;
Zheng, Guangrong;
Crooks, Peter;
Dwoskin, Linda P.;
Slack, Rachel D.;
Newman, Amy H.;
Bell, Richard L.;
Bardo, Michael T.

Publication type:

Article

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.

Published in:

Biomolecules (2218-273X), 2021, v. 11, n. 4, p. 570, doi. 10.3390/biom11040570

By:

Adhikari, Pramisha;
Xie, Bing;
Semeano, Ana;
Bonifazi, Alessandro;
Battiti, Francisco O.;
Newman, Amy H.;
Yano, Hideaki;
Shi, Lei

Publication type:

Article

Corrigendum: A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.

Published in:

Nature Communications, 2013, v. 4, n. 11, p. 2589, doi. 10.1038/ncomms3589

By:

Rickhag, Mattias;
Herborg Hansen, Freja;
Sørensen, Gunnar;
Nørgaard Strandfelt, Kristine;
Andresen, Bjørn;
Gotfryd, Kamil;
Madsen, Kenneth L.;
Vestergaard Klewe, Ib;
Ammendrup-Johnsen, Ina;
Eriksen, Jacob;
Newman, Amy H.;
Füchtbauer, Ernst-Martin;
Gomeza, Jesus;
Woldbye, David P.D.;
Wörtwein, Gitta;
Gether, Ulrik

Publication type:

Article

A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.

Published in:

Nature Communications, 2013, v. 4, n. 3, p. 1580, doi. 10.1038/ncomms2568

By:

Rickhag, Mattias;
Hansen, Freja Herborg;
Sørensen, Gunnar;
Strandfelt, Kristine Nørgaard;
Andresen, Bjørn;
Gotfryd, Kamil;
Madsen, Kenneth L.;
Vestergaard-Klewe, Ib;
Ammendrup-Johnsen, Ina;
Eriksen, Jacob;
Newman, Amy H.;
Füchtbauer, Ernst-Martin;
Gomeza, Jesus;
Woldbye, David P.D.;
Wörtwein, Gitta;
Gether, Ulrik

Publication type:

Article

The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Published in:

Addiction Biology, 2010, v. 15, n. 3, p. 312, doi. 10.1111/j.1369-1600.2010.00211.x

By:

Orio, Laura;
Wee, Sunmee;
Newman, Amy H.;
Pulvirenti, Luigi;
Koob, George F.

Publication type:

Article

The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.

Published in:

European Journal of Neuroscience, 2017, v. 45, n. 1, p. 167, doi. 10.1111/ejn.13376

By:

Mereu, Maddalena;
Chun, Lauren E.;
Prisinzano, Thomas E.;
Newman, Amy H.;
Katz, Jonathan L.;
Tanda, Gianluigi;
Bolam, Paul

Publication type:

Article

A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.

Published in:

ChemMedChem, 2016, v. 11, n. 16, p. 1819, doi. 10.1002/cmdc.201600022

By:

Mammoli, Valerio;
Bonifazi, Alessandro;
Dal Ben, Diego;
Giannella, Mario;
Giorgioni, Gianfabio;
Piergentili, Alessandro;
Pigini, Maria;
Quaglia, Wilma;
Thomas, Ajiroghene;
Newman, Amy H.;
Ferré, Sergi;
Sanchez‐Soto, Marta;
Keck, Thomas M.;
Del Bello, Fabio

Publication type:

Article

Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1187, n. 1, p. 4, doi. 10.1111/j.1749-6632.2009.05149.x

By:

Heidbreder, Christian A.;
Newman, Amy H.

Publication type:

Article

Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

Published in:

2017

By:

Yepes, Gabriel;
Guitart, Xavier;
Rea, William;
Newman, Amy H.;
Allen, Richard P.;
Earley, Christopher J.;
Quiroz, César;
Ferré, Sergi;
Quiroz, César;
Ferré, Sergi

Publication type:

journal article

In Vivo Binding of N‐Substituted Benztropine Analogs and Antagonism of Cocaine Self‐Administration.

Published in:

FASEB Journal, 2013, v. 27, p. 659.8, doi. 10.1096/fasebj.27.1_supplement.659.8

By:

Wilkinson, Derek;
Hiranita, Takato;
Mereu, Maddalena;
Tanda, Gianluigi;
Newman, Amy H.;
Katz, Jonathan L.

Publication type:

Article

The role of dopamine D3 receptors in the discriminative stimulus effects of quinpirole, cocaine, and methamphetamine in rhesus monkeys.

Published in:

FASEB Journal, 2013, v. 27, p. 659.4, doi. 10.1096/fasebj.27.1_supplement.659.4

By:

Duke, Angela N;
Green, Heather L;
Newman, Amy H;
Nader, Michael A

Publication type:

Article

Discriminative‐stimulus effects of 3,4‐methylenedioxy‐N‐methylamphetamine (MDMA) and a novel MDMA quatenary analog.

Published in:

FASEB Journal, 2013, v. 27, p. 1098.10, doi. 10.1096/fasebj.27.1_supplement.1098.10

By:

Slezak, Jonathan M.;
Mueller, Melanie;
Ricaurte, George A;
Cao, Jianjing;
Newman, Amy H.;
Katz, Jonathan L.

Publication type:

Article

Effects of Drugs on Visual Stimulus Control of Behavior in an Analog of a Drug-Discrimination Procedure.

Published in:

FASEB Journal, 2007, v. 21, n. 6, p. A782, doi. 10.1096/fasebj.21.6.a782-c

By:

Katz, Jonathan L.;
Newman, Amy H.;
Campbell, Bettye

Publication type:

Article

Subjective Effect of Monoamine Uptake Inhibitors in Rats Trained to Discriminate Citalopram.

Published in:

FASEB Journal, 2007, v. 21, n. 6, p. A779, doi. 10.1096/fasebj.21.6.a779-b

By:

Li-Bin Li;
Kopajtic, Theresa A.;
Desai, Rajeev I.;
Cyriac, George C.;
Newman, Amy H.;
Katz, Jonathan L.

Publication type:

Article

Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats.

Published in:

Frontiers in Behavioral Neuroscience, 2020, v. 13, p. 1, doi. 10.3389/fnbeh.2019.00292

By:

de Guglielmo, Giordano;
Kallupi, Marsida;
Sedighim, Sharona;
Newman, Amy H.;
George, Olivier

Publication type:

Article

Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens.

Published in:

Molecular Neurobiology, 2019, v. 56, n. 10, p. 6756, doi. 10.1007/s12035-019-1564-8

By:

Guitart, Xavier;
Moreno, Estefanía;
Rea, William;
Sánchez-Soto, Marta;
Cai, Ning-Sheng;
Quiroz, César;
Kumar, Vivek;
Bourque, Liam;
Cortés, Antoni;
Canela, Enric I.;
Bishop, Christopher;
Newman, Amy H.;
Casadó, Vicent;
Ferré, Sergi

Publication type:

Article

Corrigendum: Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET‐Based Assay of Synapsin III Binding.

Published in:

ChemMedChem, 2022, v. 17, n. 13, p. 1, doi. 10.1002/cmdc.202200243

By:

Casiraghi, Andrea;
Longhena, Francesca;
Straniero, Valentina;
Faustini, Gaia;
Newman, Amy H.;
Bellucci, Arianna;
Valoti, Ermanno

Publication type:

Article

Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET‐Based Assay of Synapsin III Binding.

Published in:

ChemMedChem, 2020, v. 15, n. 14, p. 1330, doi. 10.1002/cmdc.202000128

By:

Casiraghi, Andrea;
Longhena, Francesca;
Straniero, Valentina;
Faustini, Gaia;
Newman, Amy H.;
Bellucci, Arianna;
Valoti, Ermanno

Publication type:

Article

[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey.

Published in:

Molecules, 2018, v. 23, n. 11, p. 2737, doi. 10.3390/molecules23112737

By:

Liow, Jeih-San;
Morse, Cheryl L.;
Lu, Shuiyu;
Frankland, Michael;
Tye, George L.;
Zoghbi, Sami S.;
Gladding, Robert L.;
Shaik, Anver B.;
Innis, Robert B.;
Newman, Amy H.;
Pike, Victor W.

Publication type:

Article

Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.

Published in:

Psychopharmacology, 2010, v. 212, n. 1, p. 59, doi. 10.1007/s00213-010-1924-6

By:

Ji-Kyung Choi;
Mandeville, Joseph B.;
Chen, Y.;
Grundt, Peter;
Sarkar, Susanta;
Newman, Amy H.;
Jenkins, Bruce G.

Publication type:

Article

Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.

Published in:

Psychopharmacology, 2001, v. 154, n. 4, p. 362, doi. 10.1007/s002130000667

By:

Katz, Jonathan L.;
Agoston, Gregory E.;
Alling, Kenneth L.;
Kline, Richard H.;
Forster, Michael J.;
Woolverton, William L.;
Kopajtic, Theresa A.;
Newman, Amy H.

Publication type:

Article

Works matching AU Newman, Amy H.

Chiral aminophosphonate eluent for enantiomeric analysis of amino acids.

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.

Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Dissociable Control of Impulsivity in Rats by Dopamine D2/3 Receptors in the Core and Shell Subregions of the Nucleus Accumbens.

Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.

Corrigendum: A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.

A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.

The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.

A Novel Class of Dopamine D<sub>4</sub> Receptor Ligands Bearing an Imidazoline Nucleus.

Current perspectives on selective dopamine D<sub>3</sub> receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

In Vivo Binding of N‐Substituted Benztropine Analogs and Antagonism of Cocaine Self‐Administration.

The role of dopamine D3 receptors in the discriminative stimulus effects of quinpirole, cocaine, and methamphetamine in rhesus monkeys.

Discriminative‐stimulus effects of 3,4‐methylenedioxy‐N‐methylamphetamine (MDMA) and a novel MDMA quatenary analog.

Effects of Drugs on Visual Stimulus Control of Behavior in an Analog of a Drug-Discrimination Procedure.

Subjective Effect of Monoamine Uptake Inhibitors in Rats Trained to Discriminate Citalopram.

Dopamine D<sub>3</sub> Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats.

Biased G Protein-Independent Signaling of Dopamine D<sub>1</sub>-D<sub>3</sub> Receptor Heteromers in the Nucleus Accumbens.

Corrigendum: Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET‐Based Assay of Synapsin III Binding.

Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET‐Based Assay of Synapsin III Binding.

[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey.

Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.

Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.